(Q37104099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832538%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

review article

1 reference

title

Modulation of fluoropyrimidines by leucovorin: rationale and status (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832538%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Modulation of fluoropyrimidines by leucovorin: Rational and status (English)

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

5 December 2022

author name string

Y. M. Rustum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832538

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1832538

5 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832538%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjso.2930480525

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

https://onlinelibrary.wiley.com/doi/full/10.1002/jso.2930480525

5 December 2022

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Journal of surgical oncology. Supplement

5 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832538%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832538%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

116-123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1832538%20AND%20SRC:MED&resulttype=core&format=json

Survival and response to chemotherapy for advanced colorectal adenocarcinoma: an Eastern Cooperative Oncology Group report

19 September 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Prospective randomized reappraisal of 5-fluorouracil in metastatic colorectal carcinoma. A comparative trial with 6-thioguanine.

5 December 2022

3

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

5 December 2022

6

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Fluorinated pyrimidines as tight-binding inhibitors of thymidylate synthetase

5 December 2022

8

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Biochimica et Biophysica Acta

5 December 2022

10

473

73

Danenberg

1977

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Thymidylate synthetase purified to homogeneity from human leukemic cells

5 December 2022

11

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

5 December 2022

Molecular Pharmacology

17

25

303

Berger

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

5 December 2022

Molecular Pharmacology

18

23

190

Yin

1982

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

The effect of derivatives of folic acid on the fluorodeoxyuridylate-thymidylate synthetase covalent complex in human colon xenografts

5 December 2022

19

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Plasma and tumor tissue pharmacology of high-dose intravenous leucovorin calcium in combination with fluorouracil in patients with advanced colorectal carcinoma

5 December 2022

23

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

5 December 2022

26

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

5 December 2022

27

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group

5 December 2022

28

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy

5 December 2022

29

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

5 December 2022

30

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

Efficacy of high-dose oral leucovorin and 5-fluorouracil in advanced colorectal carcinoma. Plasma and tissue pharmacokinetics

5 December 2022

33

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

5 December 2022

35

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

A northern California Oncology Group randomized trial of single agent 5-FU vs. high-dose folinic acid + 5-FU vs. methotrexate + 5-FU + folinic acid in patients with disseminated measurable large bowel cancer

5 December 2022

37

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

5 December 2022

38

1 reference

https://api.crossref.org/works/10.1002/JSO.2930480525

5 December 2022

Identifiers

0 references

1 reference